LONDON (dpa-AFX) - AstraZeneca Plc (AZN.L, AZN), on Wednesday, announced that its wholly owned subsidiary AstraZeneca Finance LLC, has priced a three tranche global bond offering totaling $2.25
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s .